Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syneos Health Inc (NQ: SYNH ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Syneos Health Inc < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 02, 2022 Via Benzinga Recap: Syneos Health Q2 Earnings August 02, 2022 Syneos Health (NASDAQ:SYNH) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 May 24, 2022 Upgrades Via Benzinga Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook April 29, 2022 Via Benzinga Syneos Health: Q1 Earnings Insights April 29, 2022 Syneos Health (NASDAQ:SYNH) reported its Q1 earnings results on Friday, April 29, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday April 26, 2022 During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. Via Benzinga Earnings Scheduled For August 2, 2022 August 02, 2022 Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. Via Benzinga Recap: Syneos Health Q4 Earnings February 17, 2022 Syneos Health (NASDAQ:SYNH) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Syneos Health's Return On Capital Employed Insights May 06, 2022 Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) posted Q1 earnings of $46.18 million, an increase from Q4 of 39.21%. Sales dropped to $1.34 billion, a 2.69% decrease between quarters. Via Benzinga Earnings Scheduled For April 29, 2022 April 29, 2022 Companies Reporting Before The Bell • Weyerhaeuser (NYSE:WY) is projected to report quarterly earnings at $1.19 per share on revenue of $2.93 billion. Via Benzinga A Preview Of Syneos Health's Earnings April 28, 2022 Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Syneos Health... Via Benzinga Earnings Scheduled For February 17, 2022 February 17, 2022 Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. Via Benzinga Analyst Ratings For Syneos Health January 27, 2022 Within the last quarter, Syneos Health (NASDAQ:SYNH) has observed the following analyst ratings: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 April 25, 2022 Via Benzinga Looking Into Syneos Health's Return On Capital Employed February 18, 2022 Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) showed a loss in earnings since Q3, totaling $75.96 million. Sales, on the other hand, increased by 1.84% to $1.37 billion during Q4. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022 April 12, 2022 Upgrades Via Benzinga The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios February 17, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... Via Benzinga Syneos Health Reports Mixed Q4 Earnings, Provides FY22 Guidance February 17, 2022 Syneos Health Inc's (NASDAQ: SYNH) Q4 revenue increased 20.5% on a reported basis and 20.8% on a constant currency (CC) basis to Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 December 15, 2021 Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: Via Benzinga Labcorp In Talks To Merge Some Covance Assets With Syneos: Bloomberg November 12, 2021 Laboratory Corp of America Holdings (NYSE: LH) is in talks to combine some of its assets with Syneos Health Inc (NASDAQ: SYNH), reports Bloomberg citing... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021 November 05, 2021 Upgrades For IGM Biosciences Inc (NASDAQ: Via Benzinga Syneos Health, inc (SYNH) Q3 2021 Earnings Call Transcript November 03, 2021 SYNH earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Syneos Health's Return On Capital Employed Overview November 03, 2021 According to Benzinga Pro, during Q3, Syneos Health (NASDAQ:SYNH) earned $113.36 million, a 35.46% increase from the preceding quarter. Syneos Health also posted a total of $1.35... Via Benzinga The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering November 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... Via Benzinga Topics Retirement Exposures Pension The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal October 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the... Via Benzinga Exposures Product Safety Looking Into Syneos Health's Return On Capital Employed September 13, 2021 According to Benzinga Pro, during Q2, Syneos Health (NASDAQ:SYNH) earned $83.68 million, a 37.15% increase from the preceding quarter. Syneos Health also posted a total of $1.28... Via Benzinga Earnings Scheduled For November 3, 2021 November 03, 2021 Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... Via Benzinga The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs September 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout September 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.